Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6,115 JPY | +0.16% | -3.87% | +17.39% |
Apr. 03 | Sawai Group Finalizes Sale of US Subsidiary | MT |
Apr. 01 | Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd.. | CI |
Business Summary
Number of employees: 3,393
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Circulatory Organ Drug
24.5
%
| 51,415 | 26.5 % | 49,135 | 24.5 % | -4.43% |
Central Nervous System Drug
21.0
%
| 35,357 | 18.2 % | 42,147 | 21.0 % | +19.20% |
Others
9.7
%
| 18,525 | 9.6 % | 19,520 | 9.7 % | +5.37% |
Digestive Medicine
9.2
%
| 19,004 | 9.8 % | 18,357 | 9.2 % | -3.40% |
Blood - Fluid Drug
8.2
%
| 17,050 | 8.8 % | 16,448 | 8.2 % | -3.53% |
Other Metabolic Drugs
7.9
%
| 13,622 | 7.0 % | 15,827 | 7.9 % | +16.19% |
Antibiotic Preparation
4.0
%
| 7,329 | 3.8 % | 8,033 | 4.0 % | +9.61% |
Vitamin Preparation
3.7
%
| 8,851 | 4.6 % | 7,426 | 3.7 % | -16.10% |
Allergy Medication
3.3
%
| 6,884 | 3.6 % | 6,522 | 3.3 % | -5.26% |
Urogenital Organ and Anus Medicine
3.0
%
| 5,670 | 2.9 % | 6,033 | 3.0 % | +6.40% |
Drug for Tumor
2.8
%
| 5,033 | 2.6 % | 5,662 | 2.8 % | +12.50% |
Respiratory Medicine
2.6
%
| 5,076 | 2.6 % | 5,236 | 2.6 % | +3.15% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
81.7
%
| 163,841 | 84.5 % | 163,702 | 81.7 % | -0.08% |
United States
18.3
%
| 29,975 | 15.5 % | 36,642 | 18.3 % | +22.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 21-03-31 |
President | 66 | 21-03-31 | |
Toru Terashima
BRD | Director/Board Member | 64 | 21-03-31 |
Kenzo Sawai
BRD | Director/Board Member | 56 | 21-03-31 |
Tadao Tsubokura
AUD | Comptroller/Controller/Auditor | 63 | 21-03-31 |
Taku Nakaoka
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 21-03-31 |
Kenzo Sawai
BRD | Director/Board Member | 56 | 21-03-31 |
Masatoshi Ohara
BRD | Director/Board Member | 73 | 21-03-31 |
President | 66 | 21-03-31 | |
Nawomi Todo
BRD | Director/Board Member | 64 | 21-03-31 |
Toru Terashima
BRD | Director/Board Member | 64 | 21-03-31 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
SUMITOMO CORPORATION 0.07% | 858,000 | 0.07% | 22,654,272 $ |
NIPPON KAYAKU CO., LTD. 0.51% | 875,000 | 0.51% | 7,150,570 $ |
218,100 | 0.10% | 3,423,295 $ | |
224,000 | 0.11% | 3,325,161 $ | |
YAKULT HONSHA CO.,LTD. 0.04% | 148,800 | 0.04% | 2,918,036 $ |
140,000 | 3.44% | 2,272,169 $ | |
96,800 | 0.62% | 1,553,204 $ | |
ASAHI PRINTING CO.,LTD. 0.71% | 165,200 | 0.71% | 962,657 $ |
SUSMED,INC. 1.46% | 245,000 | 1.46% | 848,506 $ |
TECHNO RYOWA LTD. 0.14% | 31,460 | 0.14% | 383,841 $ |
Company contact information
SAWAI GROUP HOLDINGS Co., Ltd.
5-2-30 Miyahara Yodogawa-Ku
532-0003, Osaka
+
http://www.sawaigroup.holdingsSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.39% | 1.71B | |
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- 4887 Stock
- Company Sawai Group Holdings Co., Ltd.